Article info
PDFOriginal research
Effectiveness of antithrombotic prophylaxis in hospitalised patients with SARS-CoV-2 infection
- Correspondence to Dr Helena Quiros Ambel, Pharmacy, Hospital Universitario Fundacion Alcorcon, Alcorcon 28922, Spain; quiros.helena{at}gmail.com
Citation
Effectiveness of antithrombotic prophylaxis in hospitalised patients with SARS-CoV-2 infection
Publication history
- Received May 20, 2021
- Accepted September 28, 2021
- First published October 14, 2021.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage